Nicolas P. Pionnier
Pembroke Place
Liverpool, ENG, United Kingdom
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis.
Journal: Frontiers in microbiology
Published: November 28, 2023
NKp46+ natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infection.
Journal: Frontiers in immunology
Published: June 14, 2022
A mouse infection model and long-term lymphatic endothelium co-culture system to evaluate drugs against adult Brugia malayi.
Journal: PLoS neglected tropical diseases
Published: February 01, 2022
Onchocerca ochengi male worms implanted in SCID mice and Gerbil: Relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents.
Journal: Experimental parasitology
Published: July 26, 2020
Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis.
Journal: The Journal of clinical investigation
Published: June 02, 2020
Generation of Loa loa infective larvae by experimental infection of the vector, Chrysops silacea.
Journal: PLoS neglected tropical diseases
Published: February 07, 2020
The insufficiency of circulating miRNA and DNA as diagnostic tools or as biomarkers of treatment efficacy for Onchocerca volvulus.
Journal: Scientific reports
Published: December 06, 2019
Eosinophil-Mediated Immune Control of Adult Filarial Nematode Infection Can Proceed in the Absence of IL-4 Receptor Signaling.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 15, 2019
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.
Journal: Science translational medicine
Published: October 13, 2018
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.
Journal: Science translational medicine
Published: May 17, 2018
Last Updated: 09/26/2026